What Happens When the Clathrating Molecule Encounters the Mercury?
Your information indicates that PCA-Rx “releases” mercury from the neuron and allows it to become free floating, and then the clathrating molecule surrounds the heavy metal and removes it. Does the clathrating molecule change molecular shape when it encounters the mercury? Does the mercury run the risk of becoming bound to other tissue? How is the mercury bound up by the successor molecule after being released from the other tissue? As PCA-Rx removes the toxin from the receptor, it gives up a molecule to the damaged receptor to keep other toxins from reattaching. This nutrient molecule then remains in place until the healing process is complete. The remaining portion of the PCA-Rx then forms a three-dimensional lattice structure (or matrix) around the toxin, binding through ionic, covalent and hydrogen attachments. The toxin is completely engulfed by the PCA-Rx and is safely removed without chance of reattachment. The elimination of toxins with PCA-Rx is 85% fecal, 10% urine, and 5% va
